🌐 World · English
Current: 🌐 World · English
Global
Focused
Language
Wednesday 16 September
🌐 World · English
Current: 🌐 World · English
Global
Focused
Language
Story Australia

Changing fortunes: Is Biotech giant CSL’s $10 billion write-down a comeback story?

Australia
The brief

Make no mistake: the home-grown biotechnology company, which for decades allowed Australia serious boasting rights, is still a long way from redemption. Key points and original sources are listed below.

  • Make no mistake: the home-grown biotechnology company, which for decades allowed Australia serious boasting rights, is still a long way from redemption.S1S2
Timeline · newest first
4w Theage

Changing fortunes: Is Biotech giant CSL’s $10 billion write-down a comeback story?

Make no mistake: the home-grown biotechnology company, which for decades allowed Australia serious boasting rights, is still a long way from redemption.

4w Brisbanetimes

Changing fortunes: Is Biotech giant CSL’s $10 billion write-down a comeback story?

Make no mistake: the home-grown biotechnology company, which for decades allowed Australia serious boasting rights, is still a long way from redemption.

4w Smh

Changing fortunes: Is Biotech giant CSL’s $10 billion write-down a comeback story?

Make no mistake: the home-grown biotechnology company, which for decades allowed Australia serious boasting rights, is still a long way from redemption.

Changing fortunes: Is Biotech giant CSL’s $10 billion write-down a comeback story?

3 outlets 3 reports
The brief

Make no mistake: the home-grown biotechnology company, which for decades allowed Australia serious boasting rights, is still a long way from redemption. Key points and original sources are listed below.

  • Make no mistake: the home-grown biotechnology company, which for decades allowed Australia serious boasting rights, is still a long way from redemption.S1S2
Timeline · newest first

Sources · 3 citations

S1 TheageLead 1 report · EN
S2 Brisbanetimes 1 report · EN
S3 Smh 1 report · EN